Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment

Mesenchymal stem cells (MSCs) are promising cells to treat cartilage defects due to their chondrogenic differentiation potential. However, an inflammatory environment during differentiation, such as the presence of the cytokine TNFα, inhibits chondrogenesis and limits the clinical use of MSCs. On th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Bioeng Biotechnol
Main Authors: Voskamp, Chantal, Koevoet, Wendy J. L. M., Somoza, Rodrigo A., Caplan, Arnold I., Lefebvre, Véronique, van Osch, Gerjo J. V. M., Narcisi, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Bioengineering and Biotechnology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344141/
https://ncbi.nlm.nih.gov/pubmed/32714905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00658
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados